Literature DB >> 16010675

NSD1 mutations in Sotos syndrome.

Francesca Faravelli1.   

Abstract

Sotos syndrome is a genetic disorder characterized by a typical facial appearance, macrocephaly, accelerated growth, developmental delay, and a variable range of associated abnormalities. The NSD1 gene was recently found to be responsible for Sotos syndrome, and more than 150 patients with NSD1 alterations have been identified. A significant ethnic difference is found in the prevalence of different types of mutation, with a high percentage of microdeletions identified in Japanese Sotos syndrome patients and with intragenic mutations in most non-Japanese patients. NSD1 aberrations are rather specific for Sotos syndrome, but have also been detected in patients lacking one or more major criteria of the disorder, namely overgrowth, macrocephaly, and advanced bone age. Thus, new diagnostic criteria should be considered. Studies have reported different frequencies of mutations versus non-mutations in Sotos syndrome, thus indicating allelic or locus hetereogeneity. Although some authors have suggested genotype/phenotype correlations, further studies are needed. Copyright 2005 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16010675     DOI: 10.1002/ajmg.c.30061

Source DB:  PubMed          Journal:  Am J Med Genet C Semin Med Genet        ISSN: 1552-4868            Impact factor:   3.908


  9 in total

1.  Deletion of NSD1 exon 14 in Sotos syndrome: first description.

Authors:  Maria Piccione; Valeria Consiglio; Antonella Di Fiore; Marina Grasso; Massimiliano Cecconi; Lucia Perroni; Giovanni Corsello
Journal:  J Genet       Date:  2011-04       Impact factor: 1.166

Review 2.  Genetic considerations in the prenatal diagnosis of overgrowth syndromes.

Authors:  Neeta Vora; Diana W Bianchi
Journal:  Prenat Diagn       Date:  2009-10       Impact factor: 3.050

3.  A self-renewal program controls the expansion of genetically unstable cancer stem cells in pluripotent stem cell-derived tumors.

Authors:  Anne E Conway; Anne Lindgren; Zoran Galic; April D Pyle; Hong Wu; Jerome A Zack; Matteo Pelligrini; Michael A Teitell; Amander T Clark
Journal:  Stem Cells       Date:  2009-01       Impact factor: 6.277

4.  The methyltransferase NSD3 has chromatin-binding motifs, PHD5-C5HCH, that are distinct from other NSD (nuclear receptor SET domain) family members in their histone H3 recognition.

Authors:  Chao He; Fudong Li; Jiahai Zhang; Jihui Wu; Yunyu Shi
Journal:  J Biol Chem       Date:  2012-12-26       Impact factor: 5.157

Review 5.  Emerging epigenetic targets and therapies in cancer medicine.

Authors:  Relja Popovic; Jonathan D Licht
Journal:  Cancer Discov       Date:  2012-04-23       Impact factor: 39.397

6.  Pan-cancer stratification of solid human epithelial tumors and cancer cell lines reveals commonalities and tissue-specific features of the CpG island methylator phenotype.

Authors:  Francisco Sánchez-Vega; Valer Gotea; Gennady Margolin; Laura Elnitski
Journal:  Epigenetics Chromatin       Date:  2015-04-17       Impact factor: 4.954

7.  Histone methyltransferase MMSET/NSD2 alters EZH2 binding and reprograms the myeloma epigenome through global and focal changes in H3K36 and H3K27 methylation.

Authors:  Relja Popovic; Eva Martinez-Garcia; Eugenia G Giannopoulou; Quanwei Zhang; Qingyang Zhang; Teresa Ezponda; Mrinal Y Shah; Yupeng Zheng; Christine M Will; Eliza C Small; Youjia Hua; Marinka Bulic; Yanwen Jiang; Matteo Carrara; Raffaele A Calogero; William L Kath; Neil L Kelleher; Ji-Ping Wang; Olivier Elemento; Jonathan D Licht
Journal:  PLoS Genet       Date:  2014-09-04       Impact factor: 5.917

8.  Steric Clash in the SET Domain of Histone Methyltransferase NSD1 as a Cause of Sotos Syndrome and Its Genetic Heterogeneity in a Brazilian Cohort.

Authors:  Kyungsoo Ha; Priya Anand; Jennifer A Lee; Julie R Jones; Chong Ae Kim; Debora Romeo Bertola; Jonathan D J Labonne; Lawrence C Layman; Wolfgang Wenzel; Hyung-Goo Kim
Journal:  Genes (Basel)       Date:  2016-11-09       Impact factor: 4.096

Review 9.  Sotos syndrome.

Authors:  Geneviève Baujat; Valérie Cormier-Daire
Journal:  Orphanet J Rare Dis       Date:  2007-09-07       Impact factor: 4.123

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.